The effect of rosiglitazone and pioglitazone on VLDL apolipoprotein B metabolism in patients with type 2 diabetes

AL Brackenridge; N Jackson; F Shojaee-Moradie; AM Umpleby; D Russell-Jones

Back

The effect of rosiglitazone and pioglitazone on VLDL apolipoprotein B metabolism in patients with type 2 diabetes

Conference presentation

Peer reviewed

The effect of rosiglitazone and pioglitazone on VLDL apolipoprotein B metabolism in patients with type 2 diabetes

AL Brackenridge, N Jackson, F Shojaee-Moradie, AM Umpleby and D Russell-Jones

DIABETES, Vol.54, pp.A234-A234

65th Annual Meeting of the American-Diabetes-Association (San Diego, CA, 10/06/2005 - 14/06/2005)

01/01/2005

Abstract

Science & Technology

Life Sciences & Biomedicine

Endocrinology & Metabolism

ENDOCRINOLOGY & METABOLISM

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229501301381&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

44 Record Views

Details

Title: The effect of rosiglitazone and pioglitazone on VLDL apolipoprotein B metabolism in patients with type 2 diabetes
Creators: AL Brackenridge
N Jackson
F Shojaee-Moradie
AM Umpleby
D Russell-Jones
Contributors: AMER DIABETES ASSOC (Publisher)
Publication Details: DIABETES, Vol.54, pp.A234-A234
Conference: 65th Annual Meeting of the American-Diabetes-Association (San Diego, CA, 10/06/2005 - 14/06/2005)
Date published: 01/01/2005
Date submitted: 17/05/2017
Identifiers: 99511976002346
Academic Unit: University of Surrey
Resource Type: Conference presentation

The effect of rosiglitazone and pioglitazone on VLDL apolipoprotein B metabolism in patients with type 2 diabetes

Abstract

Files and links (1)

Metrics

Details

Usage Policy